Martin Fischer (M Fischer)

ResearcherID Scopus Author ID Loop profile ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Venues

Cell death discovery

Cell death and differentiation

Oncogene

Nucleic acids research

Leibniz-Institut für Altersforschung Fritz-Lipmann-Institut eV

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leibniz-Institut für Altersforschung Fritz-Lipmann-Institut eV Oct 01 2017

Germany

Principal Investigator, Laboratory Head, Staff Scientist :: Computational Biology

Universität Leipzig Jun 01 2016 - Sep 30 2017

Germany

Principal Investigator, Research Fellow :: Molecular Oncology

Dana-Farber Cancer Institute Mar 01 2015 - Apr 30 2017

United States

Postdoctoral Research Fellow :: Medical Oncology

Universität Leipzig - Feb 28 2015

Germany

Postdoctoral Research Fellow :: Medical School, Molecular Oncology

Universität Leipzig

Germany

Research Associate, PhD Candidate Researcher :: Medical School, Molecular Oncology

Publications

Martin Fischer, Morgan A Sammons
Determinants of p53 DNA binding, gene regulation, and cell fate decisions. Cell death and differentiation (2024)
Martin Fischer, Morgan A Sammons
Determinants of p53 DNA binding, gene regulation, and cell fate decisions. Cell death and differentiation 31 (7) (2024)
Martin Fischer, Morgan A Sammons
Determinants of p53 DNA binding, gene regulation, and cell fate decisions. Cell death and differentiation 31 (7) (2024)
Katjana Schwab, Konstantin Riege, Luis Coronel, Clara Stanko, Silke Förste, Steve Hoffmann, Martin Fischer
p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes. Cell death discovery 10 (1) (2024)
Martin Fischer, Morgan A Sammons
Determinants of p53 DNA binding, gene regulation, and cell fate decisions. Cell death and differentiation 31 (7) (2024)
Katjana Schwab, Konstantin Riege, Luis Coronel, Clara Stanko, Silke Förste, Steve Hoffmann, Martin Fischer
p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes. Cell death discovery 10 (1) (2024)
Martin Fischer, Morgan A Sammons
Determinants of p53 DNA binding, gene regulation, and cell fate decisions. Cell death and differentiation (2024)
Katjana Schwab, Luis Coronel, Konstantin Riege, Erika K Sacramento, Norman Rahnis, David Häckes, Emilio Cirri, Marco Groth, Steve Hoffmann, Martin Fischer
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell death discovery 9 (1) (2023)
Katjana Schwab, Luis Coronel, Konstantin Riege, Erika K Sacramento, Norman Rahnis, David Häckes, Emilio Cirri, Marco Groth, Steve Hoffmann, Martin Fischer
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell death discovery 9 (1) (2023)
Katjana Schwab, Luis Coronel, Konstantin Riege, Erika K Sacramento, Norman Rahnis, David Häckes, Emilio Cirri, Marco Groth, Steve Hoffmann, Martin Fischer
Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes. Cell death discovery 9 (1) (2023)
Martin Fischer, Konstantin Riege, Steve Hoffmann
The landscape of human p53-regulated long non-coding RNAs reveals critical host gene co-regulation. Molecular oncology (2023)
Martin Fischer, Konstantin Riege, Steve Hoffmann
The landscape of human p53-regulated long non-coding RNAs reveals critical host gene co-regulation. Molecular oncology (2023)
Martin Fischer, Robert Schwarz, Konstantin Riege, James A Decaprio, Steve Hoffmann
TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation. NAR cancer 4 (1) (2022)
Luis Coronel, Konstantin Riege, Katjana Schwab, Silke Förste, David Häckes, Lena Semerau, Stephan H Bernhart, Reiner Siebert, Steve Hoffmann, Martin Fischer
Transcription factor RFX7 governs a tumor suppressor network in response to p53 and stress. Nucleic acids research 49 (13) (2021)
Luis Coronel, David Häckes, Katjana Schwab, Konstantin Riege, Steve Hoffmann, Martin Fischer
p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance. Oncogene 41 (7) (2021)
Konstantin Riege, Helene Kretzmer, Arne Sahm, Simon S McDade, Steve Hoffmann, Martin Fischer
Dissecting the DNA binding landscape and gene regulatory network of p63 and p53. eLife 9 (2020)
Martin Fischer
Conservation and divergence of the p53 gene regulatory network between mice and humans. Oncogene 38 (21) (2019)
Martin Fischer, Sigrid Uxa, Clara Stanko, Thomas M Magin, Kurt Engeland
Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway. Scientific reports 7 (1) (2017)
Martin Fischer, Gerd A Müller
Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes. Critical reviews in biochemistry and molecular biology 52 (6) (2017)
Martin Fischer
Census and evaluation of p53 target genes. Oncogene 36 (28) (2017)
Martin Fischer, Patrick Grossmann, Megha Padi, James A DeCaprio
Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks. Nucleic acids research 44 (13) (2016)

Martin Fischer.css-eqlu8i{font-size:small;padding-left:4px;} (M Fischer)

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Fischer (M Fischer)